Design Verification & Validation for Medical Devices

Introduction

In the highly regulated world of MedTech and Life Sciences, the path from a “good idea” to a “marketed device” is paved with objective evidence. Design Verification & Validation (V&V) are the two pillars of this evidence. While often grouped together, they serve two distinct, vital functions under 21 CFR 820.30 and ISO 13485.

In 2026, as software and AI become integrated into almost every device, V&V has evolved from a final “checklist” into a continuous, risk-based activity. This guide explores the technical nuances of V&V, the IQ OQ PQ framework, and how to maintain a flawless Traceability Matrix to ensure patient safety and regulatory success.

Design Verification: “Did We Build the System Right?”

Design Verification is the process of confirming that the design outputs (the actual product) match the design inputs (the requirements). It is a purely technical exercise.

• Key Activities: These include Unit Testing, Integration Testing, and inspections. For hardware, it might involve stress testing or electromagnetic compatibility (EMC).
• Software Verification (IEC 62304): For software and SaMD, verification is highly structured. You must prove that the code architecture supports the requirements and that every software unit performs as expected without memory leaks or logic errors.
• The Goal: To prove that if you required the device to operate at 180°C, it actually does so under specified conditions.

Design Validation: “Did We Build the Right System?”

Design Validation happens later in the lifecycle. It is the process of proving that the device meets the User Needs and intended uses. Even if a device meets all its technical specs (Verification), it fails if a doctor cannot use it intuitively in a high-stress emergency room.

• Summative Evaluation: This involves usability testing with real users in simulated or actual environments.
• Clinical Validation: For high-risk devices, validation often requires clinical trials to prove the device achieves its intended medical claim.
• The Goal: To ensure the device is safe and effective for the end-user in the real world.

The IQ OQ PQ Framework: Beyond the Design

In the pharmaceutical and manufacturing sectors of Life Sciences, V&V extends into the equipment and processes through the IQ OQ PQ (Installation, Operational, and Performance Qualification) framework:

1. Installation Qualification (IQ): Proves the system is installed correctly according to the manufacturer’s specifications (e.g., “Is the server configured correctly?”).
2. Operational Qualification (OQ): Proves the system operates as intended across its entire operating range (e.g., “Does the alarm trigger at both the low and high thresholds?”).
3. Performance Qualification (PQ): Proves the system performs consistently under real-world load over time (e.g., “Does the software handle 1,000 concurrent users without latency?”).

Software V&V and Regression Testing

The greatest challenge in Software Verification today is the frequency of change. In an Agile or DevOps environment, a single patch can invalidate previous tests.

• Regression Testing: This is the practice of re-running verification tests after a change to ensure that new code hasn’t “broken” existing functionality.
• Automation: Because manual regression is impossible at scale, 2026 best practices dictate the use of automated testing suites that trigger every time code is committed, ensuring Continuous Verification.

The Traceability Matrix: The Auditor’s Map

The Traceability Matrix is the “Golden Thread” that connects everything. Without it, you cannot pass a 21 CFR 820.30 audit. A robust matrix must link:

• User Needs $\rightarrow$ Design Validation Tests
• Design Inputs $\rightarrow$ Design Verification Tests
• Risk Mitigations $\rightarrow$ Verification Evidence

If a single requirement lacks a corresponding test result, your device is not compliant. This matrix must be “living,” updated in real-time as the design evolves.

Visure’s Role: Automating V&V Excellence

The manual management of V&V documentation is the leading cause of “Warning Letters” from the FDA. Visure Requirements ALM acts as the automated engine for your V&V strategy:

• Automated Traceability Matrix: Visure automatically generates the matrix, flagging any “orphaned” requirements that haven’t been verified or validated.
• Test Management Integration: Connect your automated testing tools (like Selenium or LabVIEW) directly to Visure. Test results flow back into the requirements, providing instant “Pass/Fail” status for your V&V plan.
• Risk-Linked V&V: Ensure that every high-severity risk identified in your FMEA has a corresponding Software Verification test.
• Vivia AI Assistant: Use Vivia to review your Test Cases. It can detect if a test is too vague or if it fails to actually prove the underlying requirement, saving weeks of rework.

Conclusion: Quality as a Competitive Advantage

Design Verification & Validation should not be viewed as a hurdle to be cleared at the end of a project. Instead, it is the ultimate disciplined approach to engineering. By integrating Software Verification early, mastering the IQ OQ PQ steps, and maintaining a digital Traceability Matrix, manufacturers can significantly reduce the risk of recalls and regulatory delays.

In 2026, the most successful MedTech companies are those that build “V&V-ready” designs from Day 1. When the evidence of quality is baked into the process, the road to market becomes faster, safer, and much more predictable.

Check out the free trial at Visure and experience how AI-driven change control can help you manage changes faster, safer, and with full audit readiness.